• Exchange: EN Paris
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech


8.4000 EUR 0.0700 0.84%

As of 06:14:24 ET on 09/19/2014.

Company Profile for Transgene SA (TNG)

Transgene S.A. is a biotechnology company. The Company develops vaccines against cancer and infectious diseases. Transgene has products under development for lung, kidney, prostate and colorectal cancers, cutaneous T-cell lymphoma, hepatitis C, malignant melanoma, and muscular dystrophy.

Contact Information

Transgene SA

Boulevard Gonthier
Andernach Parc
Illkirch, 67403
Phone: 33-3-88-27-91-00
Fax: 33-3-88-27-91-11

Key Executives for Transgene SA (TNG)

Philippe ArchinardChairman/CEOStephane BoisselExecutive Vice President
Laurence BertaudDir:Human ResourcesNathalie AddaDir:Regulatory Affairs
Patrick MahieuxDir:Industrial OperationsThibaut Du FayetDir:Licensing & Mktg
Colin FreundDir:Business DevElisabetta CastelliDir:Investor Relations
Ghislaine GilleronGeneral Secretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil